Presence of minor drug-resistant mutations in HIV-1 subtype C patients failing antiretroviral therapy

被引:0
|
作者
Wallis, C. [1 ]
Stevens, W. [1 ,2 ]
Papathanasopolous, M. [1 ]
Simen, B. B.
Braverman, M.
Egholm, M.
Pillay, V. [3 ]
Morris, L. [3 ]
Ndung'u, T. [4 ]
Gordon, M. [4 ]
Sakwa, J. [5 ]
机构
[1] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa
[2] Natl Hlth Lab Services, Johannesburg, South Africa
[3] Natl Inst Communicable Dis, Johannesburg, South Africa
[4] Univ KwaZulu Natal, Kwa Zulu, South Africa
[5] Cato Manor, LIFElab, Johannesburg, South Africa
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:A118 / A118
页数:1
相关论文
共 50 条
  • [1] HIV drug resistant mutations in HIV-1 subtype C children failing antiretroviral therapy in South Africa
    Wallis, C. L.
    Varughese, S.
    Technau, K.
    Stevens, W.
    [J]. ANTIVIRAL THERAPY, 2009, 14 (04) : A184 - A184
  • [2] Genotype and phenotype patterns of drug-resistant HIV-1 subtype B′ (Thai B) isolated from patients failing antiretroviral therapy in China
    Ma, Liying
    Sun, Jianping
    Xing, Hi
    Si, Xefeng
    Yuan, Lin
    Guo, Yanfang
    Cheng, Hua
    Shao, Yiming
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 44 (01) : 14 - 19
  • [3] Presence of low abundance drug-resistant mutations in recently infected HIV-1 subtype C patients from South Africa
    Wallis, C. L.
    Viana, R.
    St John, E. P.
    Simen, B. B.
    Ramjee, G.
    Fidler, S.
    Rees, H.
    Weber, J.
    Stevens, W.
    [J]. ANTIVIRAL THERAPY, 2010, 15 : A35 - A35
  • [4] Should patients with drug-resistant HIV-1 continue to receive antiretroviral therapy?
    Frenkel, LM
    Mullins, JI
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07): : 520 - 522
  • [5] Persistence of drug-resistant HIV-1 and possible implications for antiretroviral therapy
    Metzner, Karin J.
    [J]. FUTURE VIROLOGY, 2006, 1 (03) : 377 - 391
  • [6] HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy
    Kantor, R
    Zijenah, LS
    Shafer, RW
    Mutetwa, S
    Johnston, E
    Lloyd, R
    Von Lieven, A
    Israelski, D
    Katzenstein, DA
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (18) : 1407 - 1413
  • [7] Selective expansion of a minor proportion of drug-resistant HIV-1 by antiretroviral pressure in vitro
    Roberts, BD
    Pau, CP
    Weinstock, H
    Heneine, W
    Butera, ST
    [J]. AIDS, 2000, 14 (17) : 2797 - 2798
  • [8] Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy
    Venturi, G
    Romano, L
    Carli, T
    Corsi, P
    Pippi, L
    Valensin, PE
    Zazzi, M
    [J]. ANTIVIRAL THERAPY, 2002, 7 (04) : 245 - 250
  • [9] Detection of minority drug resistant mutations in Malawian HIV-1 subtype C-positive patients initiating and on first-line antiretroviral therapy
    Zhou, Zhiyong
    Tang, Kevin
    Zhang, Guoqing
    Wadonda-Kabondo, Nellie
    Moyo, Kundai
    Rowe, Lori A.
    Devos, Joshua R.
    Wagar, Nick
    Zheng, Du-Ping
    Guo, Hongxiong
    Nkengasong, John
    Frace, Mike
    Sammons, Scott
    Yang, Chunfu
    [J]. AFRICAN JOURNAL OF LABORATORY MEDICINE, 2018, 7 (01)
  • [10] Drug-resistant genotyping in HIV-1 therapy
    Zöllner, B
    Feucht, HH
    Weitner, L
    Adam, A
    Laufs, R
    [J]. LANCET, 1999, 354 (9184): : 1120 - 1121